Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06298617
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2024-03-01
Brief Title:
Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis
Sponsor:
Benha University
Organization:
Benha University
Study Overview
Official Title:
Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis A Comparative Study Versus Exploratory Laparoscopy
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endometriosis EMs is one of the commonest chronic inflammatory disorder affecting women and is characterized by the presence and growth of endometrial-like glandular epithelial and stromal cells outside the uterus leading to multiple clinical symptoms affecting patients quality of life and fertility with high recurrence rate The systemic immune inflammatory index SII and systemic inflammatory response index SIRI are documented as prognostic serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies for various cancers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None